- GMP
About
UPM Pharmaceuticals is a US-based CDMO in Bristol, Tennessee that develops and manufactures oral solid and semi-solid drug products for pharmaceutical companies. It supports customers from formulation and analytical development through technology transfer, commercial manufacturing, packaging, warehousing, and microbiological testing. The company also handles high-potent compounds, controlled substances, and sustained-release products.
Services
Commercial manufacturing
Manufactures commercial drug products at scale for oral solid and semi-solid programs, including post-approval launch and sustained commercial supply.
Formulation & analytical development
Provides preformulation, formulation development, analytical method work, and scale-up support for oral solid and semi-solid drug products.
Technology transfer & scale-up support
Transfers processes from bench, pilot, clinical, or existing commercial sites to commercial manufacturing and supports scale-up to commercialization.
Quality & regulatory support
Supports QA activities, document control, batch review, product reviews, and post-marketing surveillance.
Packaging & warehousing
Provides primary and secondary packaging, storage, and supply-chain support for clinical and commercial products.
Microbiological testing lab services
Performs microbiology testing such as microbial limits, bioburden, contaminant identification, environmental monitoring, preservative efficacy, and stability testing for ICH programs.
Coated tablet manufacturing
Manufactures coated tablets and related dosage forms with enteric and other coating options.
Pharmaceutical serialization & track and trace
Provides serialization and data aggregation services for traceability and supply-chain security, including DSCSA-related support.
Oral solid dose manufacturing and handling
Manufactures tablets, capsules, mini-tablets, and bi-layer designs, including immediate-release and modified-release products.
Semi-solid manufacturing and handling
Manufactures creams, gels, ointments, topical formulations, and other semi-solid drug products.
High-potent compound handling
Handles high-potency and cytotoxic drug product manufacturing with containment controls and dedicated suites.
Controlled substance manufacturing, packaging and handling
Manufactures, packages, warehouses, and handles DEA Schedule I–V controlled substances and listed chemicals.
Sustained-release tablet and capsule manufacturing
Produces controlled-release and sustained-release dosage forms, including extended-release tablets and capsules.
Technology transfer and scale-up support
Supports transfer of products and processes from development to pilot and commercial scale, including site transfer and process development.
Quality and regulatory support
Provides quality assurance oversight, documentation control, product reviews, and post-marketing surveillance support.
Formulation and analytical development
Develops oral solid and semi-solid formulations from preformulation through scale-up, with analytical method development and validation.
Packaging and warehousing
Offers clinical and commercial packaging, serialization, storage, and warehousing services for pharmaceutical products.
Semi-solid manufacturing
Develops and manufactures creams, gels, ointments, and topical formulations under cGMP conditions.
Solid dose manufacturing
Manufactures tablets and capsules using validated processes for commercial supply.
High-potent handling
Handles high-potency compounds with specialized processing controls.
Controlled substance handling
Handles DEA-licensed controlled substances and Schedule II–V products.
Microbiological testing
Provides microbiological testing as part of its laboratory services.
- What to send
- Send the molecule, the dosage form and the constraints — potency, schedule, process, or anything that has made other CDM · Send the molecule, the dosage form and the constraints
Capabilities
- Assays and studies
- Analytical development · Stability studies · Process development · Microbial limits testing · Bioburden determination · Contaminant identification · Environmental monitoring · Preservative efficacy testing · Stability testing · In-process analytical testing · Potency testing · pH testing
11 more
ICH stability testing · Microbial testing · HPLC · UPLC · Dissolution profiling · Content uniformity · Physicochemical characterization · Solubility screening · Excipient compatibility · Polymorphism evaluation · Hygroscopicity testing - Scale and capacity
- 475,000-square-foot cGMP manufacturing facility · 34,500 sq ft of advanced analytical laboratories · 3.5B tablets annual production capabilities · 680M capsules annual production capabilities · 1,300 metric tons of semi-solids annual production capabilities · 700 million capsules per year · 4 billion tablets per year · 1,300,000 kilogram units of semi-solids per year · 1,300,000 kilogram units annually of creams and ointments · 250,000 sq ft warehouse · 15,800 sq ft DEA Approved vault space · 475,000 sq ft cGMP manufacturing facility
6 more
15,800 sq ft DEA-approved vault space · 3.5B tablets annual production capability · 680M capsules annual production capability · 1,300 metric tons of semi-solids annual production capability · 50 kg pilot batches · 1,300,000 kilogram units annually of creams and ointments on a single shift - Therapeutic areas
- Pharmaceuticals · Hormones
Instruments and platforms
- Granulators
- Tablet presses
- Fluid-bed processors
- Encapsulators
- Coating systems
- Semisolid processors
- HPLC
- UPLC
Modalities and species
- Modalities
- Small molecule · Peptide
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing
Industries served
- Pharmaceuticals
- Biotech
Company
- Type
- CDMO
Locations
- Based in
- Bristol, TN, United States
- Sites
- Bristol, United States
- Serves
- United States, pharmaceutical companies of all sizes
Contacts
- Phone
- +1 423 989 8000
Similar labs
Work here? Claim this listing